Clinical Trials Directory

Trials / Completed

CompletedNCT04195789

Assessment of Interstitial Lung Disease in Rheumatoid Arthritis by Lung Ultrasound

Status
Completed
Phase
Study type
Observational
Enrollment
34 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The high resolution chest scan is the gold standard for the screening of interstitial lung disease, but this remains an onerous examination, and irradiating. Ultrasound could be used to detect these disorders with a very good sensitivity and specificity. This exam offers the advantage of being non radiating, inexpensive, and accessible to the rheumatologist who already uses it in their daily practice. The investigators want to assess the lung ultrasound performance compared with the gold standard. Patients will be included during a regular follow-up consultation with their referent rheumatologist. If there is an indication of first line biotherapy or targeted therapy the doctor will propose to the patient to participate in the study, give him the information leaflet, collect orally non-opposition, and will complete a survey for evaluation of the general health and potential risk factors for interstitial lung.

Conditions

Interventions

TypeNameDescription
OTHERLung sonographyRealization of a lung sonography with scoring of the number of B-lines exploring 14 intercostal spaces. Duration of the exam : twenty minutes. Recording for a second analysis by another lung specialist.

Timeline

Start date
2020-08-04
Primary completion
2024-05-04
Completion
2024-06-04
First posted
2019-12-12
Last updated
2024-10-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04195789. Inclusion in this directory is not an endorsement.